Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Edenspace developed several innovative plant-based solutions including transgenic ferns for arsenic removal ("edenfernTM"), biodegradable soil amendments to reduce lead levels in turf grass, poplar trees with endophytes for enhanced trichloroethylene remediation, and enzyme-producing crops to lower costs in cellulosic ethanol production. The company received multiple SBIR/STTR grants but does not appear to have commercialized products at scale or advanced any programs into traditional clinical phases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Edenspace Systems.